Thyroid Cancer Overdiagnosis Remains High in the U.S. Despite Attempts to Curb Unnecessary Screening

Thyroid cancer incidence in the United States rose sharply over the late 20th and early 21st centuries, in a pattern that puzzled epidemiologists. Mortality from the disease barely changed during the same period. That disconnect - rising diagnoses, flat death rates - is a hallmark of overdiagnosis: the detection of cancers that would never have caused symptoms or death if left undiscovered.

Papillary thyroid cancer, the most common subtype, is the central focus of this concern. It is often slow-growing, frequently found incidentally during imaging done for other reasons, and in many cases would not progress to clinical disease within a patient's lifetime. A study published in JAMA Network Open examines the current magnitude of overdiagnosis in the U.S. and finds it remains substantial - even after applying methodologically conservative assumptions about how much true incidence might have genuinely increased.

Why distinguishing true from overdiagnosed cases is methodologically hard

Overdiagnosis cannot be measured directly in individuals. You cannot know, for a specific patient, whether their cancer would have become clinically significant. Instead, researchers estimate overdiagnosis at the population level by modeling what incidence would look like if it had tracked historical trends - then attributing the excess above that model to detection of cases that would not have caused harm.

A conservative approach to this estimate assumes that some fraction of the observed incidence increase reflects genuine biological increase in thyroid cancer, not just detection. By being generous in that assumption, researchers can establish a lower bound on overdiagnosis. The current study took this approach and still found substantial overdiagnosis, meaning that even the most optimistic interpretation of the data leaves a large residual of cases that appear to represent detection of clinically insignificant disease.

What the findings suggest for clinical practice

The study identifies nonpalpable thyroid nodules - those found incidentally on imaging, not felt during a physical examination - as a particular target for reducing unnecessary workup. Nodules that cannot be felt are typically small, and small papillary thyroid cancers are disproportionately likely to represent the overdiagnosed category.

The implication for clinical practice is straightforward in principle but complex in implementation: reducing referrals for thyroid ultrasound in asymptomatic patients without palpable findings, and adopting more conservative surveillance rather than immediate biopsy and surgery for small incidentally detected nodules. Several major medical societies have moved in this direction over the past decade, and the current study's finding that overdiagnosis remains substantial despite those efforts suggests the full effect of guideline changes has not yet been realized - or that current guidelines do not go far enough.

The stakes of overdiagnosis in thyroid cancer

Overdiagnosis is not a harmless phenomenon. Patients diagnosed with thyroid cancer face surgery - typically partial or total thyroidectomy - with associated risks including injury to the recurrent laryngeal nerve, accidental removal of the parathyroid glands, and the need for lifelong thyroid hormone replacement. Many undergo radioactive iodine treatment with its own side effects. They carry a cancer diagnosis with the associated psychological burden and insurance implications. For a cancer that would never have caused symptoms, these harms represent net harm rather than net benefit.

The countervailing risk - that reducing detection will miss some cancers that would have progressed - is real but, the study's authors argue, manageable. Papillary thyroid cancer mortality is very low, and the proportion of small papillary cancers that progress to clinically significant disease if monitored rather than resected is estimated to be small in published active surveillance studies. The tradeoff favors watchful waiting for many patients currently being operated on.